Lai Jeffrey K, Martin Michael A, Meyricke Ramona, O'neill Terry, Roberts Steven
School of Finance and Applied Statistics, Australian National University, Canberra, Australia.
J Am Coll Surg. 2007 Feb;204(2):193-200. doi: 10.1016/j.jamcollsurg.2006.11.004. Epub 2007 Jan 4.
Unplanned hospital readmissions after surgical treatment for breast cancer are an indicator of morbidity. We explore the relationship between the rate of unplanned hospital readmissions within 42 days of initial treatment and various factors, including tumor size and histology, lymph node involvement, type of surgical treatment, mastectomy, or breast-conserving surgery, and patient demographics.
Linked Western Australian cancer mortality and hospital morbidity data were used in the assessment of readmissions within a period of 42 days after initial surgical treatment for breast cancer. Planned admissions for adjuvant treatment such as chemotherapy or radiotherapy were deleted. Survival models for multiple events per subject were applied to analyze the data.
The analysis reveals that patients more likely to experience lower recurrence of short-term unplanned hospital readmissions include those with smaller tumors, private insurance, and who reside in metropolitan areas. The model also includes important two-way interaction terms involving tumor histology, area of residence, and surgical treatment, and between lymph node involvement and patient age.
This study suggests that the choice of breast-conserving surgery as a treatment for breast cancer does not invariably result in better postoperative morbidity, but rather, that other factors, including tumor size and patient demographics, play a critical role in the short term. These results differ from a previous study of longterm hospital readmissions-country of birth and method of payment were found to be associated with short-term hospital admission but not with longterm readmissions.
乳腺癌手术治疗后的非计划住院再入院是发病情况的一个指标。我们探讨初次治疗后42天内非计划住院再入院率与各种因素之间的关系,这些因素包括肿瘤大小和组织学类型、淋巴结受累情况、手术治疗类型、乳房切除术或保乳手术,以及患者人口统计学特征。
利用西澳大利亚州癌症死亡率与医院发病率的关联数据,评估乳腺癌初次手术治疗后42天内的再入院情况。删除了化疗或放疗等辅助治疗的计划内入院病例。应用针对每个受试者多个事件的生存模型来分析数据。
分析显示,更有可能出现短期非计划住院再入院较低复发率的患者包括肿瘤较小、有私人保险且居住在大城市地区的患者。该模型还包括涉及肿瘤组织学、居住地区和手术治疗的重要双向交互项,以及淋巴结受累情况与患者年龄之间的交互项。
本研究表明,选择保乳手术作为乳腺癌的治疗方法并不总是能带来更好的术后发病情况,相反,其他因素,包括肿瘤大小和患者人口统计学特征,在短期内起着关键作用。这些结果与之前一项关于长期住院再入院的研究不同——出生国家和支付方式被发现与短期住院入院有关,但与长期再入院无关。